Cadence, Inc.

Cadence, Inc. is a comprehensive medical device contract manufacturer, providing innovative solutions in product design, development, and manufacturing for MedTech and pharmaceutical sectors. Founded in 1985 in Staunton, US, Cadence, Inc. specializes in medical device contract manufacturing.

The company has remained focused on providing end-to-end solutions without significant pivots in business strategy. Cadence was acquired by Kohlberg & Company in April 2018, although financial terms were not disclosed. The company is led by CEO Alan Connor, alongside Nancy Berning and Rob Werge. Founded by Jean Butler, Cadence continues to operate independently, emphasizing its strategic growth in the medical device market.

Cadence operates as a full-service medical device contract manufacturer, specializing in a robust suite of end-to-end solutions that encompass early-stage product design, development collaboration, complete manufacturing, and comprehensive supply chain management. Their core offerings include the assembly and packaging of finished devices, custom automation solutions, and advanced manufacturing techniques such as overmolding, injection molding, precision metal stamping, and laser processing. These products primarily serve the MedTech and pharmaceutical sectors, addressing applications like cardiovascular devices, diabetes care tools, drug delivery systems, and diagnostic equipment, catering to established markets in North America and Europe. Cadence's revenue model is structured around providing contract manufacturing services to its B2B client base, primarily MedTech and pharmaceutical companies.

Transactions typically occur through partnerships and contracts, where clients commission Cadence to develop and manufacture tailored medical devices. The company’s pricing structure is established through project-based contracts, reflecting the complexity and customization of the offered services. Flagship services include complete manufacturing solutions and precision engineering capabilities, pivotal for addressing complex medical device requirements, thereby ensuring close alignment with client needs. Cadence, Inc.

is focused on expanding its product offerings and entering new markets. Plans are in place to introduce new products tailored to specific medical applications, with anticipated launches in the near future. The company aims to expand its presence in emerging markets, particularly in Asia and Latin America, by 2023. Recent funding, particularly the acquisition by Kohlberg & Company, will be leveraged to support these initiatives, enhancing their manufacturing capabilities and allowing for greater investment in research and development.